APMD (APMD) Stock Price & Analysis
APMD (APMD) fell 1.29% to USD 27.45 as of September 8, 2026 at 13:15 UTC, according to Nexqual real-time market data.
APMD last closed at USD 27.45; the session ranged USD 26.44–28.36 on volume of 233,022 shares. Market capitalization is —, with a 52-week range of USD 16.12–35.29 (NMS). Source: Nexqual, September 8, 2026 at 13:15 UTC.
Key Statistics (as of September 8, 2026 at 13:15 UTC)
| Price | USD 27.45 |
|---|---|
| Change | ▼ 1.29% (down) |
| Previous Close | USD 27.45 |
| Open | USD 27.45 |
| Day Range | USD 26.44 – 28.36 |
| 52-Week Range | USD 16.12 – 35.29 |
| Volume | 233,022 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (APMD)
Nexqual's technical model rates APMD "SELL" based on 0 bullish and 3 bearish signals across 26 daily candles, as of September 8, 2026 at 13:15 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 52.42 (neutral) |
| MACD | -0.11 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SCTX | Scribe Therapeutics Inc. | USD 28.67 | ▼ 7.22% |
| BRVE | Braveheart Bio, Inc. | USD 26.74 | ▼ 0.78% |
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| SPTX | Seaport Therapeutics, Inc. | USD 24.86 | ▼ 0.2% |
| MANE | Veradermics, Incorporated | USD 98.51 | ▲ 0.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:15 UTC. This page is informational and not investment advice.